![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Dr. McKone: Long Term Safety u0026 Efficacy of Ivacaftor in Subjects with CF Who Have the G551D Mutation (eCFReview) View |
![]() |
Michael Konstan: Results of the Phase 3 Study of Ataluren u0026 Nonsense Mutation Cystic Fibrosis (nmCF) (eCFReview) View |
![]() |
A CFTR potentiator in patients with CF and homozygous for the F508Del-CFTR mutation (eCFReview) View |
![]() |
FINALDTA (lmgiberson) View |
![]() |
CF Foundation | Gating CF Mutations, e g , G551D (Cystic Fibrosis Foundation) View |
![]() |
Tezacaftor-Ivacaftor in Residual Function Heterozygotes with Cystic Fibrosis (Alejandra Hurtado) View |
![]() |
CFTR Modulators (eCFReview) View |
![]() |
Ivacaftor - Mechanism, Development, and Pricing Controversy (Henry Schwimmer) View |
![]() |
Ivacaftor in a G551D Homozygote with Cystic Fibrosis (Luisa Castillo) View |
![]() |
Felix Ratjen discusses Efficacy of hypertonic saline in infants and young children: the ISIS study (eCFReview) View |